StonvexLoading…
StonvexStonvexStonvexCore line items from PTN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $0.00 | $4.49M | $4.85M | $1.47M |
Operating Income | $-17.46M | $-22.50M | $-32.46M | $-36.59M |
Net Income | $-17.31M | $-29.74M | $-24.04M | $-36.20M |
EPS (Diluted) | $-32.15 | $-101.16 | $-2.21 | Not available |
Total Assets | $3.27M | $10.74M | $17.94M | $36.07M |
Total Liabilities | $8.04M | $10.85M | $19.66M | $19.80M |
Cash & Equivalents | $2.56M | $9.53M | $10.98M | $29.94M |
Free Cash Flow OCF − CapEx | $-21.31M | $-31.50M | $-29.71M | $-30.18M |
Shares Outstanding | 929.60K | 358.53K | 11.66M | 9.27M |